Literature DB >> 11642397

Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or "ecstasy".

L Hassan1, C Carvalho, L A Yannuzzi, T Iida, S Negrão.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11642397     DOI： 10.1097/00006982-200110000-00030

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Central serous chorioretinopathy after blunt trauma.

Authors:  Claudia Maria Prospero Ponce; Hasan M Mohidat; Charles A Garcia
Journal:  BMJ Case Rep       Date:  2012-05-26

2.  [Bilateral retinal detachment].

Authors:  C Melzer; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

3.  Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat.

Authors:  João Martins; Miguel Castelo-Branco; Ana Batista; Bárbara Oliveiros; Ana Raquel Santiago; Joana Galvão; Eduarda Fernandes; Félix Carvalho; Cláudia Cavadas; António F Ambrósio
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

4.  Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use.

Authors:  Joseph B Alsberge; Daniel Y Lee; J Michael Jumper
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-09

5.  Central serous chorioretinopathy after dacryocystorhinostomy operation on the same side.

Authors:  Lakshmikanta Mondal; Sayan Basu; Krishnapada Baidya; Gautam Bhaduri
Journal:  Indian J Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 1.848
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.